| Publication |
Sentence |
Publish Date |
Extraction Date |
Species |
| B G Xiao, G X Zhang, C G Ma, H Lin. The cerebrospinal fluid from patients with multiple sclerosis promotes neuronal and oligodendrocyte damage by delayed production of nitric oxide in vitro. Journal of the neurological sciences. vol 142. issue 1-2. 1997-02-07. PMID:8902730. |
nitric oxide (no) may be involved in myelin and oligodendrocyte injury associated with multiple sclerosis (ms), a demyelinating disease of unknown etiology. |
1997-02-07 |
2023-08-12 |
Not clear |
| M J Crowe, J C Bresnahan, S L Shuman, J N Masters, M S Beatti. Apoptosis and delayed degeneration after spinal cord injury in rats and monkeys. Nature medicine. vol 3. issue 1. 1997-01-31. PMID:8986744. |
as cytokines have been shown to mediate oligodendrocyte death in vitro, it seems likely that chronic demyelination after cns injury shares features with chronic degenerative disorders like multiple sclerosis. |
1997-01-31 |
2023-08-12 |
rat |
| S D D'Souza, B Bonetti, V Balasingam, N R Cashman, P A Barker, A B Troutt, C S Raine, J P Ante. Multiple sclerosis: Fas signaling in oligodendrocyte cell death. The Journal of experimental medicine. vol 184. issue 6. 1997-01-30. PMID:8976190. |
multiple sclerosis: fas signaling in oligodendrocyte cell death. |
1997-01-30 |
2023-08-12 |
human |
| S D D'Souza, B Bonetti, V Balasingam, N R Cashman, P A Barker, A B Troutt, C S Raine, J P Ante. Multiple sclerosis: Fas signaling in oligodendrocyte cell death. The Journal of experimental medicine. vol 184. issue 6. 1997-01-30. PMID:8976190. |
in this study, we examined the potential of fas to contribute to oligodendrocyte (ol) injury and demyelination as they occur in the human demyelinating disease multiple sclerosis (ms). |
1997-01-30 |
2023-08-12 |
human |
| C P Genain, K Abel, N Belmar, F Villinger, D P Rosenberg, C Linington, C S Raine, S L Hause. Late complications of immune deviation therapy in a nonhuman primate. Science (New York, N.Y.). vol 274. issue 5295. 1997-01-09. PMID:8953031. |
in a marmoset model of multiple sclerosis induced by myelin oligodendrocyte glycoprotein (mog), marmosets tolerized to mog were protected against acute disease, but after tolerization treatment a lethal demyelinating disorder emerged. |
1997-01-09 |
2023-08-12 |
marmoset |
| C F Brosnan, C S Rain. Mechanisms of immune injury in multiple sclerosis. Brain pathology (Zurich, Switzerland). vol 6. issue 3. 1997-01-06. PMID:8864282. |
in this review, we address current concepts regarding the mechanisms of tissue damage that lead to demyelination and oligodendrocyte loss in multiple sclerosis. |
1997-01-06 |
2023-08-12 |
Not clear |
| N Mendel Kerlero de Rosbo, A Ben-Nu. Delineation of the minimal encephalitogenic epitope within the immunodominant region of myelin oligodendrocyte glycoprotein: diverse V beta gene usage by T cells recognizing the core epitope encephalitogenic for T cell receptor V beta b and T cell receptor V beta a H-2b mice. European journal of immunology. vol 26. issue 10. 1996-12-10. PMID:8898962. |
the nature of the autoimmune t cell response to myelin oligodendrocyte glycoprotein (mog), recently recognized as a potential target antigen in multiple sclerosis (ms), has not yet been characterized, in contrast to the t cell reactivity to other potential target antigens in ms such as myelin basic protein and proteolipid protein. |
1996-12-10 |
2023-08-12 |
mouse |
| A Ben-Nun, I Mendel, R Bakimer, M Fridkis-Hareli, D Teitelbaum, R Arnon, M Sela, N Kerlero de Rosb. The autoimmune reactivity to myelin oligodendrocyte glycoprotein (MOG) in multiple sclerosis is potentially pathogenic: effect of copolymer 1 on MOG-induced disease. Journal of neurology. vol 243. issue 4 Suppl 1. 1996-12-04. PMID:8965116. |
the autoimmune reactivity to myelin oligodendrocyte glycoprotein (mog) in multiple sclerosis is potentially pathogenic: effect of copolymer 1 on mog-induced disease. |
1996-12-04 |
2023-08-12 |
mouse |
| T Vartanian, Y Li, M Zhao, K Stefansso. Interferon-gamma-induced oligodendrocyte cell death: implications for the pathogenesis of multiple sclerosis. Molecular medicine (Cambridge, Mass.). vol 1. issue 7. 1996-06-06. PMID:8612196. |
interferon-gamma-induced oligodendrocyte cell death: implications for the pathogenesis of multiple sclerosis. |
1996-06-06 |
2023-08-12 |
Not clear |
| M P Roth, L Dolbois, N Borot, P Pontarotti, M Clanet, H Coppi. Myelin oligodendrocyte glycoprotein (MOG) gene polymorphisms and multiple sclerosis: no evidence of disease association with MOG. Journal of neuroimmunology. vol 61. issue 2. 1995-11-30. PMID:7593547. |
myelin oligodendrocyte glycoprotein (mog) gene polymorphisms and multiple sclerosis: no evidence of disease association with mog. |
1995-11-30 |
2023-08-12 |
Not clear |
| L J Hinks, S E Price, C R Mason, R J Thompso. Single strand conformation analysis of two genes contained within the first intron of the neurofibromatosis type I gene in patients with multiple sclerosis. Neuropathology and applied neurobiology. vol 21. issue 3. 1995-11-27. PMID:7477728. |
we have examined two closely related genes present in the first intron of the neurofibromatosis type i gene--the oligodendrocyte myelin glycoprotein (omgp) gene and the ecotropic viral integration 2a (evi2a) gene--in 36 patients with multiple sclerosis (ms) and 36 healthy controls. |
1995-11-27 |
2023-08-12 |
Not clear |
| I Mendel, N Kerlero de Rosbo, A Ben-Nu. A myelin oligodendrocyte glycoprotein peptide induces typical chronic experimental autoimmune encephalomyelitis in H-2b mice: fine specificity and T cell receptor V beta expression of encephalitogenic T cells. European journal of immunology. vol 25. issue 7. 1995-08-29. PMID:7621871. |
a predominant response to myelin oligodendrocyte glycoprotein (mog) was recently observed in patients with multiple sclerosis (ms). |
1995-08-29 |
2023-08-12 |
mouse |
| A A Hilton, A J Slavin, D J Hilton, C C Bernar. Characterization of cDNA and genomic clones encoding human myelin oligodendrocyte glycoprotein. Journal of neurochemistry. vol 65. issue 1. 1995-07-26. PMID:7790876. |
myelin oligodendrocyte glycoprotein (mog) is a transmembrane protein expressed only in the cns and is a possible target autoantigen in multiple sclerosis (ms). |
1995-07-26 |
2023-08-12 |
human |
| N J Scolding, P J Rayner, J Sussman, C Shaw, D A Compsto. A proliferative adult human oligodendrocyte progenitor. Neuroreport. vol 6. issue 3. 1995-07-06. PMID:7766839. |
the identification of an adult human oligodendrocyte progenitor is the first step towards developing interventional strategies for promoting repair of demyelinated lesions in patients with multiple sclerosis. |
1995-07-06 |
2023-08-12 |
human |
| T G Johns, N Kerlero de Rosbo, K K Menon, S Abo, M F Gonzales, C C Bernar. Myelin oligodendrocyte glycoprotein induces a demyelinating encephalomyelitis resembling multiple sclerosis. Journal of immunology (Baltimore, Md. : 1950). vol 154. issue 10. 1995-05-31. PMID:7537310. |
myelin oligodendrocyte glycoprotein induces a demyelinating encephalomyelitis resembling multiple sclerosis. |
1995-05-31 |
2023-08-12 |
rat |
| T G Johns, N Kerlero de Rosbo, K K Menon, S Abo, M F Gonzales, C C Bernar. Myelin oligodendrocyte glycoprotein induces a demyelinating encephalomyelitis resembling multiple sclerosis. Journal of immunology (Baltimore, Md. : 1950). vol 154. issue 10. 1995-05-31. PMID:7537310. |
the demonstrated involvement of myelin oligodendrocyte glycoprotein as a new demyelinating neural ag may provide a deeper insight into the pathogenesis of multiple sclerosis and its treatment. |
1995-05-31 |
2023-08-12 |
rat |
| K Ozawa, G Suchanek, H Breitschopf, W Brück, H Budka, K Jellinger, H Lassman. Patterns of oligodendroglia pathology in multiple sclerosis. Brain : a journal of neurology. vol 117 ( Pt 6). 1995-02-16. PMID:7820568. |
patterns of oligodendroglia pathology in multiple sclerosis. |
1995-02-16 |
2023-08-12 |
Not clear |
| K Ozawa, G Suchanek, H Breitschopf, W Brück, H Budka, K Jellinger, H Lassman. Patterns of oligodendroglia pathology in multiple sclerosis. Brain : a journal of neurology. vol 117 ( Pt 6). 1995-02-16. PMID:7820568. |
patterns of inflammation, demyelination and oligodendrocyte pathology were studied in acute multiple sclerosis and during early and late exacerbations of chronic multiple sclerosis. |
1995-02-16 |
2023-08-12 |
Not clear |
| J Roddy, I Clark, B L Hazleman, D A Compston, N J Scoldin. Cerebrospinal fluid concentrations of the complement MAC inhibitor CD59 in multiple sclerosis and patients with other neurological disorders. Journal of neurology. vol 241. issue 9. 1995-01-24. PMID:7528270. |
no significant differences were found between patients and controls, or between patients with active and those with clinically inactive demyelinating disease, providing no direct support for oligodendrocyte shedding of cd59 in multiple sclerosis. |
1995-01-24 |
2023-08-12 |
human |
| C Ffrench-Constant, B W Kiernan, R Milner, S Scott-Dre. Developmental studies of oligodendrocyte precursor cell migration and their implications for transplantation as therapy for multiple sclerosis. Eye (London, England). vol 8 ( Pt 2). 1994-12-19. PMID:7958026. |
developmental studies of oligodendrocyte precursor cell migration and their implications for transplantation as therapy for multiple sclerosis. |
1994-12-19 |
2023-08-12 |
Not clear |